Pharmakaisercentre
ActiveSummary
Pharmakaisercentre has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €216k and a net result of €51k. Equity is growing by ~3.4% per year across the filed fiscal years. Its solvency ranks better than 27% of 10407 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability74▲+2
Solvency42▲+5
Growth52▲+20
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity short (current ratio 0.49 against 0.46 in 2024; short-term debt: 40.8% and cash: 5.4% of total assets), and 83.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
16.9%
Return on assets
4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
30 d late
2024
58 d early
2023
2 d early
2022
2 d late
2021
4 d early
2020
25 d late
2019
39 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€51k▲ 36.2%
2024 · €37k
Working capital
€-266k▲ 17.8%
2024 · €-324k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€35k€-49k€-54k▼ 11.4%€49k€66k▲ 33.1%
Net result€75k▲ 177%€-27k€-68k▼ 152%€37k€51k▲ 36.2%
Equity€223k▲ 50.3%€196k▼ 12.0%€128k▼ 34.5%€166k▲ 29.1%€216k▲ 30.7%
Total assets€1.79M▼ 0.8%€1.64M▼ 8.1%€1.48M▼ 10.0%€1.39M▼ 6.3%€1.28M▼ 7.4%
Debt€1.57M▼ 5.4%€1.45M▼ 7.6%€1.35M▼ 6.7%€1.22M▼ 9.7%€1.07M▼ 12.6%
Working capital€-266k▲ 18.1%€-298k▼ 12.1%€-374k▼ 25.3%€-324k▲ 13.3%€-266k▲ 17.8%
Staff (FTE)2.5▲ 19.0%2.6▲ 4.0%3.7▲ 42.3%1.7▼ 54.1%1.7=
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 33% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.28M
Fixed assets
€1.03M ▼ 7.3%
Current assets
€258k ▼ 7.7%
Equity and liabilities €1.28M
Equity
€216k ▲ 30.7%
Debt
€1.07M ▼ 12.6%
Debt's share of the balance-sheet total falls from 88.0% to 83.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€152k▲
2024 · €151k
Cash flow
€137k▼
2024 · €139k
Current ratio
0.49▲
2024 · 0.46
Quick ratio
0.30▲
2024 · 0.28
Debt to equity
4.93▼
2024 · 7.37
ROE
23.5%▲
2024 · 22.5%
ROA
4.0%▲
2024 · 2.7%
Interest coverage
10.92▲
2024 · 10.87
Debt ≤ 1 year
€524k▼
2024 · €604k
Debt > 1 year
€542k▼
2024 · €617k
Income taxes
€2k
Staff costs
€133k▲
2024 · €132k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €141k | €149k | €156k | €132k | €133k | ▲ 0.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €103k | €102k | €104k | €101k | €86k | ▼ 14.9% |
| Other operating charges640/8 | €26k | €3k | €3k | €3k | €4k | ▲ 8.4% |
| Gross operating margin9900 | €305k | €206k | €209k | €286k | €289k | ▲ 0.9% |
| Operating profit (loss)9901 | €35k | €-49k | €-54k | €49k | €66k | ▲ 33.1% |
| Financial income75/76B | €65k | €38k | €2k | €2k | €1k | ▼ 23.7% |
| Recurring financial income75 | €65k | €38k | €2k | €2k | €1k | ▼ 23.7% |
| Financial charges65/66B | €18k | €16k | €15k | €14k | €14k | ▲ 0.3% |
| Recurring financial charges65 | €18k | €16k | €15k | €14k | €14k | ▲ 0.3% |
| Profit (loss) for the period before taxes9903 | €83k | €-27k | €-68k | €37k | €53k | ▲ 42.7% |
| Income taxes67/77 | €8k | €0 | - | - | €2k | - |
| Profit (loss) for the period9904 | €75k | €-27k | €-68k | €37k | €51k | ▲ 36.2% |
| Profit (loss) for the period to be appropriated9905 | €75k | €-27k | €-68k | €37k | €51k | ▲ 36.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.79M | €1.64M | €1.48M | €1.39M | €1.28M | ▼ 7.4% |
| Fixed assets21/28 | €1.39M | €1.29M | €1.21M | €1.11M | €1.03M | ▼ 7.3% |
| Intangible fixed assets21 | €44k | €29k | €15k | €0 | - | - |
| Tangible fixed assets22/27 | €1.35M | €1.26M | €1.19M | €1.11M | €1.03M | ▼ 7.3% |
| Land and buildings22 | €1.25M | €1.18M | €1.11M | €1.04M | €975k | ▼ 6.5% |
| Plant, machinery and equipment23 | €90k | €77k | €81k | €64k | €51k | ▼ 21.1% |
| Furniture and vehicles24 | €5k | €3k | €0 | - | - | - |
| Financial fixed assets28 | €260 | €260 | €260 | €260 | €260 | = |
| Current assets29/58 | €397k | €352k | €272k | €279k | €258k | ▼ 7.7% |
| Stocks and contracts in progress3 | €133k | €139k | €131k | €113k | €103k | ▼ 8.6% |
| Stocks30/36 | €133k | €139k | €131k | €113k | €103k | ▼ 8.6% |
| Amounts receivable within one year40/41 | €117k | €65k | €82k | €111k | €77k | ▼ 30.2% |
| Trade receivables40 | €113k | €63k | €77k | €109k | €75k | ▼ 30.9% |
| Other amounts receivable41 | €3k | €2k | €4k | €2k | €2k | ▲ 9.7% |
| Cash at bank and in hand54/58 | €128k | €135k | €48k | €45k | €69k | ▲ 52.7% |
| Deferred charges and accrued income490/1 | €19k | €13k | €11k | €11k | €8k | ▼ 21.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.79M | €1.64M | €1.48M | €1.39M | €1.28M | ▼ 7.4% |
| Equity10/15 | €223k | €196k | €128k | €166k | €216k | ▲ 30.7% |
| Contributions10/11 | €12k | €12k | €12k | €12k | €12k | = |
| Reserves13 | €210k | €210k | €210k | €210k | €210k | = |
| Non-distributable reserves130/1 | €2k | €2k | €0 | - | - | - |
| Reserves not available under the articles1311 | €2k | €2k | €0 | - | - | - |
| Distributable reserves133 | €208k | €208k | €210k | €210k | €210k | = |
| Profit (loss) carried forward14 | - | €-27k | €-94k | €-57k | €-6k | ▲ 89.1% |
| Amounts payable17/49 | €1.57M | €1.45M | €1.35M | €1.22M | €1.07M | ▼ 12.6% |
| Amounts payable after more than one year17 | €901k | €796k | €706k | €617k | €542k | ▼ 12.0% |
| Financial debts170/4 | €901k | €796k | €706k | €617k | €542k | ▼ 12.0% |
| Amounts payable within one year42/48 | €664k | €651k | €646k | €604k | €524k | ▼ 13.1% |
| Current portion of amounts payable after more than one year42 | €103k | €105k | €109k | €89k | €74k | ▼ 16.5% |
| Trade debts44 | €67k | €55k | €77k | €101k | €59k | ▼ 41.8% |
| Suppliers440/4 | €67k | €55k | €77k | €101k | €59k | ▼ 41.8% |
| Taxes, remuneration and social security45 | €34k | €40k | €21k | €17k | €25k | ▲ 47.6% |
| Taxes450/3 | €14k | €14k | €5k | €2k | €8k | ▲ 392% |
| Remuneration and social security454/9 | €20k | €25k | €17k | €16k | €18k | ▲ 13.1% |
| Other amounts payable47/48 | €459k | €451k | €438k | €396k | €366k | ▼ 7.7% |
| Accrued charges and deferred income492/3 | €2k | €2k | €620 | €508 | €452 | ▼ 11.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €75k | €-27k | €-68k | €37k | €51k | ▲ 36.2% |
| + Depreciation and write-downs630 | €103k | €102k | €104k | €101k | €86k | ▼ 14.9% |
| Operating cash flow (approximation) | €177k | €76k | €36k | €139k | €137k | ▼ 1.2% |
| Investment in fixed assets (approximation) | - | €-2k | €-21k | €0 | €-5k | - |
| Change in cash | - | €7k | €-87k | €-3k | €24k | ▲ 1,030% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
31-12
Financial
Equity above €200kEq €216k ▲30.7%
2 profitable years in a row build equity to €216k.
03-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Back to profitnet €37k
Net result €37k after 2 loss-making years.
31-12
Financial
Equity above €150kEq €166k ▲29.1%
Equity rises from €128k to €166k.
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Weakest financial yearnet €-68k
Net result drops to €-68k, the lowest in the series; recovery starts the following year.
02-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 2 days late
2022
27-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €75k ▲177%
Net result €75k, the highest in the series.
31-12
Financial
Equity above €200kEq €223k ▲50.3%
2 profitable years in a row build equity to €223k.
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 25 days late
Show earlier events
2020
31-12
Financial
Back to profitnet €27k
Net result €27k after one loss-making year.
08-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 39 days late
2019
12-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 12 days late
2018
26-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
02-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sprimont · 1 establishment unit since 2014
Ground area
676 m²
Building footprint
152 m²
Volume, LiDAR
1,434 m³
Parcel 62100D1357/00C006, Wallonia · tallest building 12.2 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
PHARMAKAISERCENTRE
since 20142.237.220.272
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62100D1357/00C006 | Wallonia | 676 m² | 1 · 152 m² | 12.2 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LIWOMA
BE 0804.674.287
Kontich · Eq €216,381
PHARMACIE VAN INNIS VINCENT
BE 0871.703.762
Etterbeek · Eq €216,644
3-FOLIA
BE 0712.690.276
Gent · Eq €216,222
Apotheek Premereur
BE 0439.299.142
Denderleeuw · Eq €216,785
APOTHEEK SOETE
BE 0675.803.552
Brugge · Eq €216,099
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 3,549 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-12-2014
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.